New research on GLP-1s point to a clear need for more sustainable models—ones that pair access with clinical oversight, behavior change and cost management strategies.
Employee demand for GLP-1s continues to surge as prices are primed to start lowering, prompting many orgs to rethink plan design to balance employee expectations and costs.
While nearly three-quarters of healthcare executives believe their own organizations will be as strong or stronger in 2026, more than half expect the healthcare industry overall to face a worse year ahead, according to a new survey of industry executives.
